Segment & Geographic Data
Quant-Grade Normalized (live API)
API & CSV Delivery
Inotiv Inc's Business Segments
Inotiv Inc's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Segment Data As of Q2 FY2026
Reportable Segments
2
Largest Segment
Research Models and Services
Total Revenue
$ 118
Countrys Reported
2
Revenue Share by Reportable Segment - Q2 FY2026
- Research Models and Services60%
- Discovery and Safety Assessment40%
Revenue by Reportable Segment - Q2 FY2026
| Segment | Revenue (Millions) | % of Total |
|---|---|---|
| Research Models and Services | $ 71 | 60% |
| Discovery and Safety Assessment | $ 47 | 40% |
Revenue Share by Country - Q2 FY2026
- United States88.1%
- Netherlands5.4%
Revenue by Geographic Country - Q2 FY2026
| Country | Revenue (Millions) | % of Total |
|---|---|---|
| United States | $ 104 | 88.1% |
| Netherlands | $ 6 | 5.4% |
Revenue by Product & Service Category - Q2 FY2026
- Product49.1%
- Service10.9%
Revenue by Product & Service Category - Q2 FY2026
| Category | Revenue (Millions) | % of Total |
|---|---|---|
| Product | $ 58 | 49.1% |
| Service | $ 13 | 10.9% |
Product and service categories are a supplemental disclosure and are not required to sum to consolidated revenue or to the reportable segments above.
Description of Inotiv Inc
Inotiv Inc. is a leading provider of contract research services to the pharmaceutical, biotechnology, and medical device industries. The company was founded in 1992 and is headquartered in West Lafayette, Indiana, USA. Inotiv has a long history of providing high-quality analytical and bioanalytical services, as well as other technical services such as pharmacokinetic and toxicology studies.
Inotiv's services include bioanalysis, preclinical and clinical pharmacology, and clinical trial management. Their bioanalysis services help clients determine the concentration of drug molecules in blood, plasma, or other fluids. The preclinical and clinical pharmacology services include dose ranging studies, pharmacokinetics and pharmacodynamics studies, as well as toxicology studies, where they use animal models to evaluate the safety of drugs. Inotiv's clinical trial management services involve the coordination and management of clinical trials, including the selection of investigators, the design and implementation of protocols, and the management of data.
Inotiv is an accredited laboratory with over 20 years of experience in the industry, and their team of scientists and technicians possess the expertise and the knowledge to provide clients with the highest quality services. They have state-of-the-art facilities and equipment, which allows them to offer a broad range of analytical and bioanalytical services that meet or exceed regulatory requirements.
Inotiv's clients include pharmaceutical and biotechnology companies, as well as academic and government institutions. They have a significant presence in North America, Europe, and Asia, and their services have been relied upon to support the development of hundreds of drugs and medical devices.
In terms of financial performance, Inotiv has consistently grown revenues year over year, and has been profitable for over a decade. As of 2021, the company has a market capitalization of more than $350 million, making it a relatively small player in the contract research industry.
Overall, Inotiv's commitment to excellence in science, rigorous quality assurance, and a focus on customer satisfaction has made it a highly trusted partner to many of the world's leading pharmaceutical and biotechnology companies.
Inotiv's services include bioanalysis, preclinical and clinical pharmacology, and clinical trial management. Their bioanalysis services help clients determine the concentration of drug molecules in blood, plasma, or other fluids. The preclinical and clinical pharmacology services include dose ranging studies, pharmacokinetics and pharmacodynamics studies, as well as toxicology studies, where they use animal models to evaluate the safety of drugs. Inotiv's clinical trial management services involve the coordination and management of clinical trials, including the selection of investigators, the design and implementation of protocols, and the management of data.
Inotiv is an accredited laboratory with over 20 years of experience in the industry, and their team of scientists and technicians possess the expertise and the knowledge to provide clients with the highest quality services. They have state-of-the-art facilities and equipment, which allows them to offer a broad range of analytical and bioanalytical services that meet or exceed regulatory requirements.
Inotiv's clients include pharmaceutical and biotechnology companies, as well as academic and government institutions. They have a significant presence in North America, Europe, and Asia, and their services have been relied upon to support the development of hundreds of drugs and medical devices.
In terms of financial performance, Inotiv has consistently grown revenues year over year, and has been profitable for over a decade. As of 2021, the company has a market capitalization of more than $350 million, making it a relatively small player in the contract research industry.
Overall, Inotiv's commitment to excellence in science, rigorous quality assurance, and a focus on customer satisfaction has made it a highly trusted partner to many of the world's leading pharmaceutical and biotechnology companies.
Inotiv Inc operates within the life sciences industry, specifically focusing on drug development and bioanalytical services. Its offerings are structured into two main segments: Pharmaceutical Development Services (PDS) and Bioanalytical Services (BAS). Below is a comprehensive overview of each segment, product, and service that Inotiv Inc provides.
Segments
1. Pharmaceutical Development Services (PDS)
Inotiv’s PDS segment caters to pharmaceutical, biotechnology, and medical device industries by providing an extensive suite of research services tailored to the drug development lifecycle. The services in this segment encompass:
- Drug Discovery: This covers early-phase research activities essential for identifying and validating drug targets. Inotiv provides access to technologies for in vitro and in vivo testing, which are critical in evaluating potential drug candidates.
- Drug Development: Services here include the progression of promising compounds through the developmental pipeline. This involves formulation development, scale-up, and preclinical and clinical testing necessary to ensure product viability and safety.
- Bioanalysis: Utilized to measure drug concentration, systemic exposure, and the pharmacokinetic profile of drug candidates through advanced analytical techniques.
- Metabolism and Pharmacokinetics: Inotiv conducts studies aimed at understanding how drugs are metabolized in the body, including absorption, distribution, metabolism, and excretion (ADME).
- Toxicology: This involves comprehensive safety assessments including acute and chronic toxicity testing, as well as specialized toxicology assessments focusing on potential side effects of drug candidates.
- Pathology: Services provided within pathology include detailed examinations of tissues and organs through necropsy, histopathology, and safety pathology.
The PDS segments emphasis on customized solutions enables clients to address complex challenges throughout the drug development process.
Bioanalytical Services (BAS)
Focusing on the analytical aspect, the BAS segment offers specialized services to measure and analyze biological and chemical compounds. Key components of this segment include:
- Bioanalysis: This includes a spectrum of techniques such as chromatography and mass spectrometry to measure drug levels and metabolites in biological samples.
- Biomarker Analysis: The identification and quantification of biomarkers are vital for understanding disease mechanisms and treatment efficacy, contributing to drug development and regulatory submissions.
- Pharmacokinetic Analysis: Inotiv provides services to assess drug performance in terms of concentration-time profiles and the implications for dosing regimens.
- ADME Studies: Studies designed to evaluate the absorption, distribution, metabolism, and excretion characteristics of drug candidates to ensure proper formulation and delivery.
- Data Management and Statistical Analysis: These services support clients in the interpretation and regulatory reporting of complex data sets generated throughout the analytical process.
Products
Inotiv Inc manufactures and markets a variety of products that enhance the capabilities of its PDS and BAS segments:
1. Drug Discovery Services
This encompasses a suite of products including various in vitro and in vivo testing systems, assays for target validation, and early-stage compound profiling tools, all aimed at facilitating the drug discovery process.
Bioanalytical Services
The company provides an array of bioanalytical tools and services, including:
- Chromatography and Mass Spectrometry: Essential equipment and solutions for quantitative analysis of drugs and biomarkers.
- Immunoassays: Technologies used to quantitatively measure antigens or antibodies, vital for clinical trials.
Inotiv Software
Inotiv has developed proprietary software platforms that assist pharmaceutical companies with data management, enhancing the accuracy of statistical analysis, and ensuring quality control throughout the research process.
Services
The range of services offered by Inotiv across its PDS and BAS segments is designed to meet the varied needs of its clients:
1. Drug Development Services
These include comprehensive offerings such as detailed preclinical and clinical testing, as well as non-clinical safety assessments to support drug approval processes.
Bioanalysis Services
Focusing on pharmacokinetic analysis, metabolite identification, and bioequivalence studies, these services enable a deeper understanding of how drugs behave in biological systems.
Toxicology Services
Inotiv’s toxicology offerings cover extensive safety evaluation protocols, including assessments for acute and chronic toxicity, safety pharmacology, and genotoxicity testing.
Pathology Services
With a strong emphasis on detailed pathology assessments, Inotiv provides services that span necropsy examinations, toxicologic pathology, and professional peer review to ensure the highest standard of analysis.
Regulatory Support Services
Inotiv assists clients in navigating the regulatory environment associated with drug development. This involves consulting services for regulatory strategy, submission support for Investigational New Drug (IND) and New Drug Applications (NDA), and preparation for FDA audits.
Overall, Inotiv Inc positions itself as a comprehensive partner in pharmaceutical research and development, offering a well-rounded suite of services and products aimed at expediting drug discovery, improving safety assessments, and enhancing bioanalytical capabilities—all crucial for bringing innovative therapies to market efficiently.
Segments
1. Pharmaceutical Development Services (PDS)
Inotiv’s PDS segment caters to pharmaceutical, biotechnology, and medical device industries by providing an extensive suite of research services tailored to the drug development lifecycle. The services in this segment encompass:
- Drug Discovery: This covers early-phase research activities essential for identifying and validating drug targets. Inotiv provides access to technologies for in vitro and in vivo testing, which are critical in evaluating potential drug candidates.
- Drug Development: Services here include the progression of promising compounds through the developmental pipeline. This involves formulation development, scale-up, and preclinical and clinical testing necessary to ensure product viability and safety.
- Bioanalysis: Utilized to measure drug concentration, systemic exposure, and the pharmacokinetic profile of drug candidates through advanced analytical techniques.
- Metabolism and Pharmacokinetics: Inotiv conducts studies aimed at understanding how drugs are metabolized in the body, including absorption, distribution, metabolism, and excretion (ADME).
- Toxicology: This involves comprehensive safety assessments including acute and chronic toxicity testing, as well as specialized toxicology assessments focusing on potential side effects of drug candidates.
- Pathology: Services provided within pathology include detailed examinations of tissues and organs through necropsy, histopathology, and safety pathology.
The PDS segments emphasis on customized solutions enables clients to address complex challenges throughout the drug development process.
Bioanalytical Services (BAS)
Focusing on the analytical aspect, the BAS segment offers specialized services to measure and analyze biological and chemical compounds. Key components of this segment include:
- Bioanalysis: This includes a spectrum of techniques such as chromatography and mass spectrometry to measure drug levels and metabolites in biological samples.
- Biomarker Analysis: The identification and quantification of biomarkers are vital for understanding disease mechanisms and treatment efficacy, contributing to drug development and regulatory submissions.
- Pharmacokinetic Analysis: Inotiv provides services to assess drug performance in terms of concentration-time profiles and the implications for dosing regimens.
- ADME Studies: Studies designed to evaluate the absorption, distribution, metabolism, and excretion characteristics of drug candidates to ensure proper formulation and delivery.
- Data Management and Statistical Analysis: These services support clients in the interpretation and regulatory reporting of complex data sets generated throughout the analytical process.
Products
Inotiv Inc manufactures and markets a variety of products that enhance the capabilities of its PDS and BAS segments:
1. Drug Discovery Services
This encompasses a suite of products including various in vitro and in vivo testing systems, assays for target validation, and early-stage compound profiling tools, all aimed at facilitating the drug discovery process.
Bioanalytical Services
The company provides an array of bioanalytical tools and services, including:
- Chromatography and Mass Spectrometry: Essential equipment and solutions for quantitative analysis of drugs and biomarkers.
- Immunoassays: Technologies used to quantitatively measure antigens or antibodies, vital for clinical trials.
Inotiv Software
Inotiv has developed proprietary software platforms that assist pharmaceutical companies with data management, enhancing the accuracy of statistical analysis, and ensuring quality control throughout the research process.
Services
The range of services offered by Inotiv across its PDS and BAS segments is designed to meet the varied needs of its clients:
1. Drug Development Services
These include comprehensive offerings such as detailed preclinical and clinical testing, as well as non-clinical safety assessments to support drug approval processes.
Bioanalysis Services
Focusing on pharmacokinetic analysis, metabolite identification, and bioequivalence studies, these services enable a deeper understanding of how drugs behave in biological systems.
Toxicology Services
Inotiv’s toxicology offerings cover extensive safety evaluation protocols, including assessments for acute and chronic toxicity, safety pharmacology, and genotoxicity testing.
Pathology Services
With a strong emphasis on detailed pathology assessments, Inotiv provides services that span necropsy examinations, toxicologic pathology, and professional peer review to ensure the highest standard of analysis.
Regulatory Support Services
Inotiv assists clients in navigating the regulatory environment associated with drug development. This involves consulting services for regulatory strategy, submission support for Investigational New Drug (IND) and New Drug Applications (NDA), and preparation for FDA audits.
Overall, Inotiv Inc positions itself as a comprehensive partner in pharmaceutical research and development, offering a well-rounded suite of services and products aimed at expediting drug discovery, improving safety assessments, and enhancing bioanalytical capabilities—all crucial for bringing innovative therapies to market efficiently.